Furthermore, in our in vivo efficacy studies, we observed that during the initial week of treatment, the tumor inhibitory effect in the 5-FU treated positive control group resembled that of the medium-dose Nectin-4 NDC treated group (5 mg/kg). This evidence concerns the gene NECTIN1 and neoplasm.